Actively Recruiting
Cardiovascular Structure and Function in Mucopolysaccharidosis Types I and IVA A Four-Year Observational Study Tracking Heart and Blood Vessel Health
Led by Children's Hospital of Orange County · Updated on 2026-10-21
240
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how heart and blood vessel problems develop in people with Mucopolysaccharidosis MPS, a group of rare genetic disorders. The study focuses on substances called GAGs and proteoglycans to see their effects on the heart. It also aims to find reliable blood and urine markers to track heart health and guide future treatments. The study compares changes in blood vessels and protein levels between people with MPS and those without it. Participants are divided into two groups those diagnosed with MPS types I or IVA and healthy individuals without MPS matched by age and biological sex. The study is observational, meaning no treatments are given, and it involves yearly tests for four years. These tests include carotid ultrasound to image neck blood vessels, echocardiogram to examine heart function, blood draws, and urine collections. During the study, participants will have these assessments once a year for four years to monitor changes in heart and blood vessel health. Researchers will measure heart and carotid artery structure and function, along with biomarkers in blood and urine, to understand disease progression. The total participation time spans four years, with regular evaluation to track cardiovascular health and related markers.
CONDITIONS
Brief Title
Cardiac Structure and Function in MPS
Research Team
N
Nina Movsesyan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here